Abstract

COVID-19 is a respiratory infection caused by a coronavirus that spreads from person to person. In the present situation, the COVID-19 pandemic is a swiftly rising phase. Now the time is the second wave ending phase of coronavirus and the third wave coming phase of coronavirus in India. The pandemic situation is moving forward all over India. Nowadays, the worldwide COVID-19 pandemic structure is a very hazardous situation. The COVID-19 vaccine can suppress this situation and gain preventive measures against coronavirus. In producing the COVID-19 vaccine, the Indian medical board plays a significant role. The COVID-19 vaccines have exhibited 90%–95% efficacy in preventing symptomatic COVID-19 infections. Against COVID-19, for emergency purposes, the Indian medical board has approved three vaccines: Covishield, Covaxin, and Sputnik V. Generally, the Indian people are embarrassed about the vaccination of COVID-19. All people are thinking about which vaccine is best for them. This labyrinth can be evaluated effectively using the multi-criteria decision-making (MCDM) technique. Therefore, we have proposed a novel MCDM technique for selecting COVID-19 vaccines. The main aim of this paper is to develop an MCDM technique based on a λ-weighted ranking interpreter (Rλ+,Rλ−). The first time, we have defined positive and negative λ-weighted rank interpreter for the ranking of single-valued bipolar neutrosophic (SVbN) number. Additionally, positive and negative λ-weighted values and positive and negative λ-weighted ambiguity of an SVbN-number are formulated here. Some important, valuable theorems and corollary of SVbN-number are formulated. To show the applicability of the proposed MCDM technique, we have considered a real decision-making problem where ratings of the alternatives are with SVbN-numbers.

Full Text

Published Version
Open DOI Link

Get access to 250M+ research papers

Discover from 40M+ Open access, 3M+ Pre-prints, 9.5M Topics and 32K+ Journals.

Sign Up Now! It's FREE

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call